Early therapeutic intervention in treatable neuromuscular disorders, specifically Spinal Muscular Atrophy, preserves muscle function, improves quality of life, and increases survival rates. Participants will attain an enhanced understanding of early clinical presentation and current management guidelines to reduce diagnostic delay.